According to our new market research study on “The global Antibody Testing Market to 2028 – Global Analysis and Forecast – by products, indication and end user,” the market is expected to grow from US$ 7,260.00 million in 2021 to US$ 11,578.47 million by 2028. The market is estimated to grow with a CAGR of 6.9% from 2021 to 2028. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system to help stop intruders from harming the body. An antibody test is a screening for the presence of antibodies in the blood. The body makes antibodies when it fights infection, like COVID-19 or when patients get a vaccine, like a flu shot. That’s how immunity to a virus is built. These tests are also called serology tests.

Market leaders operating in the market have undertaken various organic growth strategies in the antibody testing Market. The antibody testing market majorly consists of the players including Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Inc, Beckton, Dickinson And Company, F. Hoffmann La Roche, Agilent Technologies, Diasorin, Zeus Scientific, Abcam, Trinity Biotech and among others. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.

Factors such as rising number of covid-19 cases worldwide, increasing prevalence of chronic diseases and growing geriatric population are expected to boost the growth of the global antibody testing market. However, the market is likely to get impacted by the limitations of antibody screening tests during the forecast period.

Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system to help stop intruders from harming the body. An antibody test is a screening for the presence of antibodies in the blood. The body makes antibodies when it fights infection, like COVID-19 or when patients get a vaccine, like a flu shot. That’s how immunity to a virus is built. These tests are also called serology tests.

Based on products, the market is segmented into kits, chemical & reagents, and consumables. In 2021, the kits segment accounted for the highest share of the market. The growth of this segment is attributed to a large number of manufacturers like Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and others and higher adoption of kits in various research processes. The same segment is likely to register the highest CAGR in the global antibody testing market during the forecast period. The kits segment is further sub-segmented into serological test kits, immunoglobulin kits, and lateral flow assay kits. The kit is the most promising segment of the global antibody testing market that will contribute to tremendous growth during the forecast period. Additionally, these products are frequently used in various research processes, which further is expected to propel growth. Further, in response to the growing COVID-19 pandemic and shortages of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling rapid and easy-to-use devices to facilitate testing outside of laboratory settings. These simple test kits are based either on the detection of proteins from the COVID-19 virus in respiratory samples (e.g. sputum, throat swab) or detection, in blood or serum, of human antibodies generated in response to Infectious Diseases.

Global antibody testing market, based on indication is segmented into pregnancy, cardiovascular diseases, autoimmune diseases, infectious diseases, oncology, endocrine diseases and others. The infectious diseases segment held the largest share of the market in 2021, and same segment is anticipated to register the highest CAGR of 8.2% in the market during the forecast period.

Get a Sample Copy of the Report@

Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. Antibody detection is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with reagent red cells. Determination of specific antibodies to viral and bacterial pathogens and parasites facilitates the correct therapeutic measures to be taken. Antibody testing is critical for implementing an effective and efficient public health strategy to minimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally.

COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade. Till date no definitive treatment against COVID 19 has been established. Hence, lack of definitive therapy offers significant opportunities for global antibody testing market as US FDA has recently approved use of plasma therapy for critically ill COVID 19 patients. In long run antibody testing market will have significant growth prospects as many market players has received emergency use authorization for their newly developed antibody tests. All such developments will add up to the future demand for global antibody testing market.

Thermo Fisher Scientific; Abbott Laboratories; Bio-Rad Laboratories, Inc.; Beckton, Dickinson And Company; F. Hoffmann La Roche; Agilent Technologies; DiaSorin; Zeus Scientific; ABCAM; Trinity Biotech are among the leading companies operating in the global antibody testing market.  

By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Greece, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South and Central America (Brazil, Argentina, and Rest of South and Central America).

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Technology, Media, and Telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, technology, products, and services etc., which helps our clients to gain a deeper analytical understanding of various research topics.

Contact Us

If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876

Asia-Pacific: +91 20 6727 8686